Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/1996
12/17/1996CA1338800C Hepatitis delta and diagnostics and vaccines
12/16/1996WO1996039508A1 Fibroblast growth factor 13
12/16/1996CA2220988A1 Fibroblast growth factor 13
12/12/1996WO1996039630A1 Detection of htlv antibodies utilizing recombinant proteins
12/12/1996WO1996039629A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/12/1996WO1996039518A1 Lead binding polypeptides and nucleotides coding therefor
12/12/1996WO1996039515A1 Human vascular endothelial growth factor 2
12/12/1996WO1996039513A2 Ebnerin cloning of a secreted von ebner's gland protein
12/12/1996WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR
12/12/1996WO1996039509A1 Fibroblast growth factor 15
12/12/1996WO1996039507A1 Fibroblast growth factor 11
12/12/1996WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996WO1996039488A1 Process for controlling sialylation of proteins produced by mammalian cell culture
12/12/1996WO1996039443A1 Peptide analogs and their use as haptens to elicit catalytic antibodies
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039437A1 Human g-protein chemokine receptor hdgnr10
12/12/1996WO1996039434A1 Human g-protein receptor hgber32
12/12/1996WO1996039426A1 Hypoxia inducible factor-1 and method of use
12/12/1996WO1996039420A1 Human criptin growth factor
12/12/1996WO1996039187A1 Method for treating molluscum contagiosum resulting from hiv infection
12/12/1996WO1996039186A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
12/12/1996WO1996039185A1 Treatment and diagnosis of prostate cancer
12/12/1996WO1996039183A1 Compositions and methods for targeted delivery of effector molecules
12/12/1996WO1996039180A1 Immunogen preparation with hapten
12/12/1996WO1996039177A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996DE19530273C1 Monoclonal antibodies specific for cell-surface glyco-protein MGC-24
12/12/1996CA2562211A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2562162A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2413012A1 Human vascular endothelial growth factor 2
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223439A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits
12/12/1996CA2223419A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses
12/12/1996CA2223291A1 Treatment and diagnosis of prostate cancer
12/12/1996CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses
12/12/1996CA2223235A1 Detection of htlv antibodies utilizing recombinant proteins
12/12/1996CA2223038A1 A c5a-like seven transmembrane receptor
12/12/1996CA2222643A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2221274A1 Human g-protein receptor hgber32
12/12/1996CA2218329A1 Fibroblast growth factor-11
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/12/1996CA2217216A1 Human chemokine beta-13
12/12/1996CA2216912A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2215286A1 Human criptin growth factor
12/11/1996EP0747707A1 Propoxyphene derivatives for immunoassay reagents
12/11/1996EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof
12/11/1996EP0747481A1 Epstein-Barr virus peptides and antibodies against these peptides
12/11/1996EP0747394A2 Hepatitis GB virus synthetic peptides and uses thereof
12/11/1996EP0747063A2 Neisseria meningitidis capsular polysaccharide conjugates
12/11/1996EP0747060A2 Anti-plasma-antibody-preparation
12/11/1996EP0747059A1 Anti-inflammatory containing monoclonal antibodies having reactivity with sialyl-lewis x sugar chains originating in hemangioendothelial cell membrane
12/11/1996EP0746621A1 Expression of proteins on bacterial surface
12/11/1996EP0746619A1 Human phosphodiesterase type ivc, and its production and use
12/11/1996EP0746613A1 Recombinant humanized anti-fb5 antibodies
12/11/1996EP0746609A1 Transgenic non-human animals capable of producing heterologous antibodies
12/11/1996EP0746398A1 Antibody purification
12/11/1996EP0746336A1 Prodrugs activated by targeted catalytic proteins
12/11/1996EP0593435B1 A polypeptide
12/11/1996EP0583390B1 Detection of cardiovascular lesions
12/11/1996EP0496832B1 Inhibition of padgem-mediated cell binding
12/11/1996EP0491865B1 Conjugate vaccine for group b streptococcus
12/11/1996CN1137758A Methods of prolonged suppression of humoral immunity
12/11/1996CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation
12/11/1996CN1137529A Production process for modified low temp. ethanolic human gammaglobulin
12/10/1996US5583204 Using affinity columns
12/10/1996US5583203 VLA proteins
12/10/1996US5583202 Antigenized antibodies and genes
12/10/1996US5583201 Using apolipoprotein e variant as marker of peripheral nerve damage
12/10/1996US5583199 Obtained from cytoplasmic or nuclear eukaryotic cell fractions, induced in hemopoietic factor-dependent cell lines by cytokine
12/10/1996US5583005 Binding a mixture of labelled monoclonal antibodies to the human ige which has been bound to the immobilized antibody
12/10/1996US5583002 Determining the level of expression of at least one selected t-cell antigen receptor protein or a protein in the t-lymnphocyte signal transduction pathway
12/10/1996US5582998 For demonstrating presence of tumor necrosis factor binding protein i in body fluids
12/10/1996US5582996 Bifunctional antibodies and method of preparing same
12/10/1996US5582990 Nucleotide sequence which codes antigen used for detection of lyme disease
12/10/1996US5582968 For immunoassay
12/10/1996US5582862 Administering to treat myocardial infarction or blood clot
12/10/1996US5582826 Monoclonal antibodies which bind the gamma chain of human interleukin-2 receptor
12/10/1996US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
12/10/1996CA2060507C Factor xa based anticoagulant compositions
12/10/1996CA1338782C Antibodies for use in determining human glycoalbumin
12/10/1996CA1338781C Ligands and methods for augmenting b-cell proliferation
12/10/1996CA1338777C Methods and compositions for preventing secondary cataracts
12/08/1996CA2178538A1 Hepatitis gb virus synthetic peptides and uses thereof
12/08/1996CA2178537A1 Hepatitis gb virus recombinant proteins and uses thereof
12/08/1996CA2178526A1 Nucleotide sequence of the mycoplasma genitalium genome, fragments thereof, and uses thereof
12/05/1996WO1996038571A2 Recombinant polypeptide cytotoxins for cancer treatment
12/05/1996WO1996038569A1 Human ice homolog
12/05/1996WO1996038565A1 RECOMBINANT HERPESVIRUS WITH THE USE OF gB GENE PROMOTER
12/05/1996WO1996038558A2 A human purinergic p2u receptor
12/05/1996WO1996038557A1 Hepatocyte growth factor receptor antagonists and uses thereof
12/05/1996WO1996038550A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor
12/05/1996WO1996038543A1 Modified cells and methods for inhibiting xenograft rejection
12/05/1996WO1996038483A1 Monoclonal and polyclonal antibodies against recombinant human xanthine oxidase, method for their use and a kit containing same
12/05/1996WO1996038482A1 Monoclonal antibodies for human mesenchymal stem cells
12/05/1996WO1996038481A1 Anti-gp130 monoclonal antibodies
12/05/1996WO1996038474A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
1 ... 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 ... 1494